First Time Loading...

Amgen Inc
NASDAQ:AMGN

Watchlist Manager
Amgen Inc Logo
Amgen Inc
NASDAQ:AMGN
Watchlist
Price: 277.37 USD 1.25% Market Closed
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one AMGN stock under the Base Case scenario is 254.92 USD. Compared to the current market price of 277.37 USD, Amgen Inc is Overvalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMGN Relative Value
Base Case
254.92 USD
Overvaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.3
P/S
P/S
Price to Sales
5.3
vs History
23
vs Industry
64
Median 3Y
4.9
Median 5Y
4.9
Industry
8.1
Forward
4.4
More Details
22.1
P/E
P/E
Price to Earnings
22.1
vs History
11
vs Industry
7
Median 3Y
19.7
Median 5Y
18.4
Industry
26.2
Forward
13.9
More Details
17.5
P/OCF
P/OCF
Price to OCF
17.5
vs History
6
vs Industry
9
Median 3Y
13.3
Median 5Y
12.8
Industry
22.6
More Details
4.8
P/FCFE
P/FCFE
Price to FCFE
4.8
vs History
82
vs Industry
11
Median 3Y
9.6
Median 5Y
10.2
Industry
21.3
More Details
23.8
P/B
P/B
Price to Book Value
23.8
vs History
26
vs Industry
3
Median 3Y
21.4
Median 5Y
14.6
Industry
2.5
More Details
7.1
EV/S
EV/S
Enterprise Value to Sales
7.1
vs History
7
vs Industry
46
Median 3Y
5.9
Median 5Y
5.9
Industry
7.3
Forward
6
More Details
10.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.2
vs History
6
vs Industry
40
Median 3Y
7.8
Median 5Y
7.7
Industry
9.1
More Details
16.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
16.4
vs History
6
vs Industry
7
Median 3Y
11.9
Median 5Y
11.7
Industry
4.4
Forward
10.9
More Details
24.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
24.6
vs History
6
vs Industry
6
Median 3Y
16.4
Median 5Y
15.8
Industry
4.3
Forward
13
More Details
23.7
EV/OCF
EV/OCF
Enterprise Value to OCF
23.7
vs History
6
vs Industry
7
Median 3Y
15.9
Median 5Y
15.2
Industry
5.4
More Details
27.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
27.3
vs History
7
vs Industry
6
Median 3Y
17.7
Median 5Y
16.5
Industry
3.2
More Details
3
EV/IC
EV/IC
Enterprise Value to IC
3
vs History
36
vs Industry
43
Median 3Y
2.9
Median 5Y
2.9
Industry
5
More Details

Multiples Across Competitors

AMGN Competitors Multiples
Amgen Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Amgen Inc
NASDAQ:AMGN
148.5B USD 5.3 22.1 16.4 24.6
US
Abbvie Inc
NYSE:ABBV
285.6B USD 5.3 59.3 12.9 19.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.6B USD 10.5 28.6 22.9 24
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
98.8B USD 7.5 25 16.6 18.2
AU
CSL Ltd
ASX:CSL
133B AUD 6.1 35.1 21.3 26.4
US
Gilead Sciences Inc
NASDAQ:GILD
81.6B USD 3 168.6 6.8 8.9
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
42.6B USD 6.2 -9 -9.5 -8.2
US
Biogen Inc
NASDAQ:BIIB
31.5B USD 3.3 27 13.8 17.3
KR
Celltrion Inc
KRX:068270
39.3T KRW 18.1 73.4 44.9 61.8
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Summary
AMGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMGN stock valuation using valuation multiples.
Wall Street Estimates
AMGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.